Assessment of tumor biomarkers for prognosis in interstitial lung disease associated with connective tissue disease: a prospective study
Authors:
Open Access
- 1 November 2024
- journal article
- research article
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (11) , 7383-7396
Abstract
Background: There is uncertainty with respect to the baseline tumor markers and clinical outcomes for patients with connective tissue disease-associated interstitial lung disease (CTD-ILD). The study aimed to assess the association between baseline tumor markers and progressive pulmonary fibrosis (PPF) and prognosis. Methods: This is a prospective cohort study. Serum levels of nine tumor markers, including carcinoembryonic antigen (CEA) and carbohydrate antigen 125 (CA125), neuron-specific enolase (NSE), squamous cell carcinoma (SCC) antigen, cytokeratin fraction 21-1 (CYFRA21-1), serum ferritin (SF), alpha-fetoprotein (AFP) and carbohydrate antigen 724 (CA724) were collected at baseline in patients with CTD-ILD and healthy controls (HCs). Logistic regression and receiver operating characteristic (ROC) curves were used to assess the strength of baseline tumor markers in identifying PPF in CTD-ILD. Correlation analysis was performed to explore associations between tumor markers and disease severity. The relationship of prognosis and these markers was also evaluated. Results: There were 224 patients with CTD-ILD and 63 HCs included in the analysis. The serum CEA and CA125 levels were significantly higher in the PPF group than in the non-PPF and HC groups. The area under the ROC curve (AUC) of CEA was 0.64 [95% confidence interval (CI): 0.56–0.72], the highest among the tested tumor markers. For CA125, the AUC was 0.59 (95% CI: 0.51–0.68). Patients were then stratified into low-titre and high-titre groups based on the median levels of CEA or CA125. Compared with the low CEA group, patients in the high CEA group showed a higher risk for PPF [odds ratio (OR): 3.42, 95% CI: 1.74–6.72, PConclusions: Circulating CEA may be associated with pulmonary fibrosis progression and prognosis of CTD-ILD.Keywords
This publication has 46 references indexed in Scilit:
- Carcinoembryonic antigen predicts waitlist mortality in lung transplant candidates with idiopathic pulmonary fibrosisEuropean Journal of Cardio-Thoracic Surgery, 2018
- 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroupsAnnals of the Rheumatic Diseases, 2017
- An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort studyThe Lancet Respiratory Medicine, 2017
- 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndromeAnnals of the Rheumatic Diseases, 2017
- Clinical Characteristics of Connective Tissue Disease-Associated Interstitial Lung Disease in 1,044 Chinese PatientsChest, 2016
- Overlap connective tissue disease syndromesAutoimmunity Reviews, 2013
- Serum carcinoembryonic antigen correlates with severity of idiopathic pulmonary fibrosisRespirology, 2012
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosusArthritis & Rheumatism, 2012
- The Significance of Elevated Tumor Markers Among Patients With Idiopathic Pulmonary Fibrosis Before and After Lung TransplantationChest, 2012
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2010